Pura Vida Investments, LLC Aurinia Pharmaceuticals Inc. Transaction History

Pura Vida Investments, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$10.0 - $14.52 $505,750 - $734,349	-50,575 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$12.3 - $18.73 $622,072 - $947,269	50,575 New	50,575 $657,000
Q4 2020 Feb 16, 2021	SELL	$12.94 - $16.05 $647,000 - $802,500	-50,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$13.19 - $16.66 $659,500 - $833,000	50,000 New	50,000 $737,000
Q2 2020 Aug 14, 2020	SELL	$14.12 - $18.33 $1.4 Million - $1.81 Million	-98,913 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$11.34 - $21.46 $1.91 Million - $3.61 Million	-168,137 Reduced 62.96%	98,913 $1.44 Million
Q4 2019 Feb 14, 2020	BUY	$3.88 - $21.42 $1.04 Million - $5.72 Million	267,050 New	267,050 $5.41 Million

214

58.3M

1.14M

1.51M

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.14B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.